UMinn-Rochester Chancellor Steve Lehmkuhle, Rochester Chamber's John Wade, Minn. DEED Commissioner Katie Clark Sieben, Rochester Mayor Ardell Brede
CHICAGO — Collaboration has no borders. That was clearly evident last evening when nearly 200 people — an international cross section of economic developers, researchers and government officials — crowded a networking reception hosted by the state of Minnesota. Many of us from Mayo Clinic are here at BIO 2013, the global biotech conference, which migrates from city to city each year. We haven’t heard the first estimates of attendance yet, but the norm is around 18,000 registrants. They come to share ideas, attend workshops and presentations, and find ways to work together, as client and vendor, but just as often as partners (either large or small P) in some kind of venture. The cost of technology development and the demand for new innovations mean no one can go it alone any more. Many of the people here from Minnesota represent small biotech startups seeking larger markets. And many are here to attract business investment or research involvement in their home state or country. Last night Minnesota’s commissioner of Employment and Economic Development spoke, along with the mayor of Rochester, Minnesota and the chancellor of the University of Minnesota Rochester. But the talks were brief and people focused on networking for over two hours, including government representatives from Germany and Japan. I spoke with people from Ireland, Sweden and Canada. Researchers may have little funding for travel these days, so they make the most of this one week when what seems like the entire world is present under one roof. It happens in networking events like last night’s and in one-on-one “speed dating” sessions facilitated by the conference organizers. The next few days may mean the beginning of profitable relationships or a connection that leads to a new discovery or company. To not be present and participating means you are opting out of the biotechnology world.
Sometimes paths and purposes cross and good things happen. Internationally-read science writer Kendall Powell was on campus in Rochester today to speak to Mayo Graduate School students on the prospects for writing about science as a career. Kendall has written for a variety of outlets, including the journal Nature. She is one of the authors of the Science Writer’s Handbook, due out next week from the National Association of Science Writers. As a freelance journalist, Kendall is part of this growing sector of professionals that aren’t part of a publication’s staff but still provide an increasing percentage of the news on the pages. She is shown here with Bruce Horazdovsky, Ph.D., associate dean of the Graduate School, who hosted her talk.
While he states that doesn’t think that this drug, or other similar drugs, will be “a passport to eating gluten with impunity,” Dr. Murray is hopeful that they may reduce the sensitivity of a patient with celiac disease, which could allow for low-level gluten contamination without injury or symptoms.
On the heels of a major advancement in the field of regenerative medicine, Mayo Clinic and others continue to look to the future and the potential of regenerative medicine. Today, Genetics Policy Institute (GPI) announced details of the 9th annual World Stem Cell Summit — the largest and most comprehensive multi-track interdisciplinary stem cell conference aimed at uniting the global stem cell community and accelerating cures.
Dr. Murray, along with fellow keynote speaker, Peter Green, M.D., Director of the Celiac Disease Center at Columbia University, will be addressing questions of:
- Why has the prevalence of celiac disease increased?
- How can we prevent the development of celiac disease?
- What is the increased risk of mortality for those with celiac disease?
- How can we improve the timeline for a cure?
- Why must I be diagnosed if I know I feel better not eating gluten?
- What exactly is non-celiac gluten sensitivity?
Dr. Murray will also be moderating a panel discussion featuring leaders of pharmaceutical companies that will cover emerging treatments and breaking therapies in celiac disease.
Visit the CDF website for more information and registration information.
Dr. Murray discusses why gluten-free diets are on the rise:
Using patients’ own cells, Mayo researchers used a special cocktail of proteins to train them to become heart-like and successfully introduced them to the individuals’ cardiac tissue that had been damaged by disabling heart attacks. All participants in this Phase II trial improved, both in the pumping ability of their hearts and in their ability to walk greater distances with comfort. A major advancement from Andre Terzic, M.D., Ph.D., and the Center for Regenerative Medicine. Watch a great video on this story.
In this final installment, Annerieke discusses some interesting findings and conclusions from her project, interviews participants about their exer-gaming experiences, and offers one last insight into working in the United States.
Participants discuss their exer-gaming experiences:
Annerieke’s final insight into her working experience in the United States:
The study also took a close look at vital gluten, a food additive extracted from wheat flour that is added to breads and other baked goods to improve the baking qualities of their dough. Because vital gluten can be found in most commercial varieties of bread, as well as in many fast foods, its consumption has tripled since 1977.
In celebration of National Laboratory Professionals Week, students from the Mayo Clinic Clinical Laboratory Science Program produced a short video explaining what sparked their interest in laboratory science. Mayo Clinic has hundreds of young professionals working in its research labs with hundreds of their counterparts in clinical laboratories, often just across a hall.
The video is for a contest hosted by the American Society of Clinical Pathology (ASCP). The video with the most YouTube views wins, so please take a few minutes to watch the video and share it.